PE interest in pain management remains strong heading into Q4 2026, with 12 announced deals through September — one short of the 13 completed in all of 2025 and already two ahead of 2024's pace. PE-backed buyers accounted for 10 of those 12 deals, and 31 of the 36 pain deals announced since January 2024 were add-ons to existing platforms, signaling that consolidation in the space is accelerating rather than slowing.
This BGP Sector Spotlight covers Q3 2026 pain management M&A market activity, including deal volume trends, active platform buyers, sponsor exit timing, and what the current environment means for independent pain practice owners evaluating a transaction. Key takeaways include the strength of the add-on market, five platforms from the 2022–23 formation wave now approaching the four-year mark of their hold periods, and two sponsor exits already completed since 2024.
For additional information or to discuss potential partnership opportunities and the transaction process, please contact Andrew Adams at andrew.adams@bayshoregp.com.
Download the Full Report